The Biden administration on Oct. 21 issued a new proposed rule that would require health insurance providers to cover an ...

As groundbreaking studies continue to reshape the human immunodeficiency virus (HIV) landscape, emerging therapies and ...

Gilead has grown to become a leader in the fight against HIV and has announced efforts to improve access to a new, highly ...

The measure waives the need for a primary care physician’s prescription for HIV medications like PrEP and Doxy PEP.

Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

With Gilead sprinting to a likely approval next year for its long-acting pre-exposure | With GSK girding for competition from ...

The companies have presented positive Phase II data during an oral session at IDWeek 2024, in Los Angeles, US.

GILD's recent upbeat data on lenacapavir underscore the investigational drug???s potential to prevent HIV in the targeted ...

Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

Long-acting injectable PrEP is now to be covered without cost-sharing under Affordable Care Act rules, the Biden ...

From oral PrEP, to injectables, rings, and implants, this year's HIV Research for Prevention conference was all about options ...

From an anal PrEP douche to the first women-controlled HIV prevention product, here's all the new HIV prevention products ...